1 Vizoso F.J. et al. Mesenchymal stem cells in homeostasis and systemic diseases: Hypothesis, evidences, and therapeutic opportunities. Int. J. Mol. Sci.20(15), 3738 (2019).
2 Murray P.A. & Woolf A.S. Using stem and progenitor cells to recapitulate kidney development and restore renal function. Curr. Opin. Organ Transplant.19(2), 140-144 (2014).
3 Brown C. et al. Mesenchymal stem cells: Cell therapy and regeneration potential. J. Tissue Eng. Regen. Med. 13(9), 1738-1755 (2019).
4 Dekel B. et al. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. J. Am. Soc. Nephrol. 17(12), 3300-3314 (2006).
5 Leuning D.G. et al. The human kidney capsule contains a functionally distinct mesenchymal stromal cell population. PLOS one 12(12), e187118 (2017).
6 Leuning D.G. et al. Clinical-grade isolated human kidney perivascular stromal cells as an organotypic cell source for kidney regenerative medicine. Stem Cells Transl. Med. 6(2), 405-418 (2017).
7 Huang Y. et al. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection. Transplantation 90(12), 1307-1311 (2010).
8 Huang Y. et al. Kidney-derived stromal cells modulate dendritic and T cell responses. J. Am. Soc. Nephrol. 20(4), 831-841 (2009).
9 Jiang M. H. et al. Nestin+ kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury. Biomaterials 50, 56-66 (2015).
10 Wilson M.R. & Zoubeidi A. Clusterin as a therapeutic target. Expert Opin. Ther. Targets 21(2), 201-213 (2017).
11 Park S., Mathis K.W., & Lee I. K. The physiological roles of apolipoprotein J/clusterin in metabolic and cardiovascular diseases. Rev. Endocr. Metab. Disord. 15(1), 45-53 (2014).
12 Abdallah B.M., Alzahrani A.M. & Kassem M. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway. Bone 110, 221-229 (2018).
13 Jung G.S. et al. Clusterin attenuates the development of renal fibrosis. J. Am. Soc. Nephrol. 23(1), 73-85 (2012).
14 Guo J. et al. Relationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injury. BMC Nephrol. 17(1), 133 (2016).
15 Rosenberg M. E. et al. Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol. Cell Biol. 22(6), 1893-1902 (2002).
16 Nguan C.Y. et al. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 306(7), F724-F733 (2014).
17 Zhou W. et al. Loss of clusterin expression worsens renal ischemia-reperfusion injury. Am. J. Physiol. Renal Physiol. 298(3), F568-F578 (2010).
18 Gupta A. K. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J. Stem Cells 7(4), 776 (2015).
19 Liu B. et al. Mesenchymal stroma cells in peritoneal dialysis effluents from patients. Hum. Cell 30(2), 51-59 (2017).
20 Liang P. et al. Prevention of Prostate Tumor Development by Stimulation of Antitumor Immunity Using a Standardized Herbal Extract (Deep Immune(R)) in TRAMP Mice. Evid. Based Complement Alternat. Med. 2018, 9707543 (2018).
21 Pittenger M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411), 143-147 (1999).
22 Dominici M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4), 315-317 (2006).
23 Alnasser H. A. et al. Requirement of clusterin expression for prosurvival autophagy in hypoxic kidney tubular epithelial cells. Am. J. Physiol. Renal Physiol. 310(2), F160-F173 (2016).
24 Vizoso F. J. et al. Mesenchymal stem cell secretome: Toward cell-free therapeutic strategies in regenerative medicine. Int. J. Mol. Sci. 18(9), 1852 (2017).
25 Harrell C. R. et al. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells 8(5), 467 (2019).
26 Huang J. et al. Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance. Stem Cell Res. Ther. 12(1), 197 (2021).
27 Andrianova N. V. et al. Kidney cells regeneration: Dedifferentiation of tubular epithelium, resident stem cells and possible niches for renal progenitors. Int. J. Mol. Sci. 20(24), 6326 (2019).
28 Lee P. T. et al. Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. Stem Cells 28(3), 573-584 (2010).
29 Kitamura S. et al. Establishment and characterization of renal progenitor like cells from S3 segment of nephron in rat adult kidney. FASEB J. 19(13), 1789-1797 (2005).
30 Lazzeri E. et al. Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. Nat. Commun. 9(1), 1344 (2018).
31 Weng X. et al. Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys. Immunol. Cell Biol. 99(3), 274-287 (2021).
32 Berebichez-Fridman R. & Montero-Olvera P. R. Sources and clinical applications of mesenchymal stem cells: State-of-the-art review. Sultan Qaboos Univ. Med. J. 18(3), e264-e277 (2018).
33 Mafi R. et al. Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature. Open Orthop. J. 5 Suppl 2, 242-248 (2011).
34 Plotkin M. D. & Goligorsky M. S. Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. Am. J. Physiol. Renal Physiol. 291(4), F902-F912 (2006).
35 Cakiroglu F. et al. Differences of cell surface marker expression between bone marrow- and kidney-derived murine mesenchymal stromal cells and fibroblasts. Cell Mol. Biol. 62(12), 11-17 (2016).
36 Bruno S., Chiabotto G. & Camussi G. Concise review: different mesenchymal stromal/stem cell populations reside in the adult kidney. Stem Cells Transl. Med. 3(12), 1451-1455 (2014).
37 Leong K. G. et al. Generation of a prostate from a single adult stem cell. Nature 456(7223), 804-808 (2008).
38 Pleniceanu O., Harari-Steinberg O. & Dekel B. Concise review: Kidney stem/progenitor cells: differentiate, sort out, or reprogram? Stem Cells 28(9), 1649-1660 (2010).
39 van de Rijn M. et al. Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc. Natl. Acad. Sci. USA 86(12), 4634-4638 (1989).
40 Putra A. et al. Hypoxia-preconditioned MSCs have superior effect in ameliorating renal function on acute renal failure animal model. Open Access Maced J. Med. Sci. 7(3), 305-310 (2019).
41 Aggarwal S. et al. Human CD133+ renal progenitor cells induce erythropoietin production and limit fibrosis after acute tubular injury. Sci. Rep. 6, 37270 (2016).
42 Marcheque J. et al. Concise reviews: Stem cells and kidney regeneration: An update. Stem Cells Transl. Med. 8(1), 82-92 (2019).
43 Santeramo I. et al. Human kidney-derived cells ameliorate acute kidney injury without engrafting into renal tissue. Stem Cells Transl. Med. 6(5), 1373-1384 (2017).
44 Shrestha S. et al. Characterization and determination of cadmium resistance of CD133+/CD24+ and CD133-/CD24+ cells isolated from the immortalized human proximal tubule cell line, RPTEC/TERT1. Toxicol. Appl. Pharmacol. 375, 5-16 (2019).
45 Rodríguez-Rivera C. et al. Clusterin: Always protecting. Synthesis, function and potential issues. Biomed Pharmacother. 134, 111174 (2021).
46 Rohne P., Prochnow H. & Koch-Brandt C. The CLU-files: disentanglement of a mystery. Biomol. Concepts 7(1), 1-15 (2016).
47 Guan Q. et al. From humans to experimental models: The cytoprotective role of clusterin in the kidney. Med. Surg. Urol. 3(2), 134 (2014).
48 Li C. et al. Multiple roles of microRNA-100 in human cancer and its therapeutic potential. Cell Physiol. Biochem. 37(6), 2143-2159 (2015).
49 Fritz I. B. et al. Ram rete testis fluid contains a protein (clusterin) which influences cell-cell interactions in vitro. Biol. Reprod. 28(5), 1173-1188 (1983).
50 Dairi G. et al. Transcriptome-Based analysis of molecular pathways for clusterin functions in kidney cells. J. Cell Physiol. 231(12), 2628-2638 (2016).
51 Poulios E., Trougakos I. P. & Gonos E. S. Comparative effects of hypoxia on normal and immortalized human diploid fibroblasts. Anticancer Res. 26(3A), 2165-2168 (2006).
52 Mohyeldin A., Garzon-Muvdi T. & Quinones-Hinojosa A. Oxygen in stem cell biology: A critical component of the stem cell niche. Cell Stem Cell 7(2), 150-161 (2010).
53 Ezashi T., Das P. & Roberts R. M. Low O2 tensions and the prevention of differentiation of hES cells. Proc. Natl. Acad. Sci. USA 102(13), 4783-4788 (2005).
54 Zhang W. & Edwards A. Oxygen transport across vasa recta in the renal medulla. Am. J. Physiol. Heart Circ. Physiol. 283(3), H1042-H1055 (2002).
55 Geng Y. et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Res. Ther. 5(3), 80 (2014).
56 Sica A. & Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122(3), 787-795 (2012).
57 Ferrante C. J. & Leibovich S. J. Regulation of macrophage polarization and wound healing. Adv. Wound Care (New Rochelle) 1(1), 10-16 (2012).